Drug Profile

DKB 15003

Alternative Names: DKB-15003

Latest Information Update: 20 Dec 2021

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

15 Dec 2021 Phase-III clinical trials in Dyslipidaemias in South Korea (unspecified route) as of December 2021 (DongKoo Bio&Pharma pipeline; December 2021)
29 Apr 2020 DongKoo Bio&Pharma has patent protection for DKB 15003 in South Korea in April 2020
31 Dec 2018 DongKoo Bio&Pharma completes a phase I trial in Dyslipidaemias in South Korea in 2018

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com